{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T21:06:02Z","timestamp":1771707962120,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.clgc.2025.102493","type":"journal-article","created":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T22:54:20Z","timestamp":1767308060000},"page":"102493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Main Genomic Findings in Penile Cancer: An Update"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6945-8261","authenticated-orcid":false,"given":"Herney Andr\u00e9s","family":"Garc\u00eda-Perdomo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Tagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clgc.2025.102493_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.clgc.2025.102323","article-title":"Impact of TP53 alterations on clinical outcomes in penile squamous cell carcinoma","volume":"23","author":"Li","year":"2025","journal-title":"Clin Genitourin Cancer"},{"issue":"12","key":"10.1016\/j.clgc.2025.102493_bib0002","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48002","article-title":"Genomic profiles and clinical outcomes of penile squamous cell carcinoma with elevated tumor mutational burden","volume":"6","author":"Necchi","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.clgc.2025.102493_bib0003","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2024.04.032","article-title":"TP53 Mutations emerge as a critical biomarker in penile cancer, superseding Human papillomavirus status","volume":"86","author":"Chahoud","year":"2024","journal-title":"Eur Urol"},{"issue":"14","key":"10.1016\/j.clgc.2025.102493_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14143514","article-title":"Mutational signature and integrative Genomic analysis of Human papillomavirus-associated penile squamous cell carcinomas from Latin American patients","volume":"14","author":"Canto","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.clgc.2025.102493_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oncolo\/oyae220","article-title":"Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational study","volume":"30","author":"Monteiro","year":"2025","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.clgc.2025.102493_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clgc.2025.102323","article-title":"Impact of TP53 alterations on clinical outcomes in penile squamous cell carcinoma","volume":"23","author":"Li","year":"2025","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2025.102493_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100689","article-title":"Altered TP53, CDKN2A, ATM, EPHA7, POT1, CHEK1, GRIN2A, and EGFR predict shorter survival in penile squamous cell carcinoma","volume":"38","author":"Hojn\u00fd","year":"2025","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102493_bib0008","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.eururo.2024.03.038","article-title":"Single-cell atlas of penile cancer reveals TP53 mutations as a driver of an aggressive phenotype, irrespective of Human papillomavirus status, and provides clues for treatment personalization","volume":"86","author":"Elst","year":"2024","journal-title":"Eur Urol"},{"issue":"24","key":"10.1016\/j.clgc.2025.102493_bib0009","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1002\/cncr.34982","article-title":"Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of Human papillomavirus status on immune-checkpoint inhibitor-related biomarkers","volume":"129","author":"Nazha","year":"2023","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2025.102493_bib0010","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/ijms23010251","article-title":"Pathogenesis of penile squamous cell carcinoma: molecular update and systematic review","volume":"23","author":"Ribera-Cortada","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.clgc.2025.102493_bib0011","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1186\/s12885-022-10432-7","article-title":"Increased HRD score in cisplatin resistant penile cancer cells","volume":"22","author":"Winkelmann","year":"2022","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.clgc.2025.102493_bib0012","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/ijc.33990","article-title":"Mutations in the telomerase reverse transcriptase promoter and PIK3CA gene are common events in penile squamous cell carcinoma of Italian and Ugandan patients","volume":"150","author":"Starita","year":"2022","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2025.102493_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15592294.2024.2305081","article-title":"Hypomethylation at H19DMR in penile squamous cell carcinoma is not related to HPV infection","volume":"19","author":"da Silva Santos","year":"2024","journal-title":"Epigenetics"},{"key":"10.1016\/j.clgc.2025.102493_bib0014","doi-asserted-by":"crossref","first-page":"875939","DOI":"10.3389\/fgene.2022.875939","article-title":"Upregulated miRNAs on the TP53 and RB1 binding seedless regions in high-risk HPV-associated penile cancer","volume":"13","author":"da Silva","year":"2022","journal-title":"Front Genet"},{"issue":"10","key":"10.1016\/j.clgc.2025.102493_bib0015","doi-asserted-by":"crossref","first-page":"100250","DOI":"10.1016\/j.modpat.2023.100250","article-title":"Different mutational landscapes in Human papillomavirus\u2013induced and Human papillomavirus\u2013independent invasive penile squamous cell cancers","volume":"36","author":"Ermakov","year":"2023","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.clgc.2025.102493_bib0016","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.urolonc.2025.04.011","article-title":"Genomic profiling of urological malignancies using tissue-based next generation sequencing","volume":"43","author":"Alruwaii","year":"2025","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2025.102493_bib0017","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.pathol.2023.03.010","article-title":"Immune cell infiltration, tumour budding, and the p53 expression pattern are important predictors in penile squamous cell carcinoma: a retrospective study of 152 cases","volume":"55","author":"Hrudka","year":"2023","journal-title":"Pathology"},{"issue":"12","key":"10.1016\/j.clgc.2025.102493_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.48002","article-title":"Genomic profiles and clinical outcomes of penile squamous cell carcinoma with elevated tumor mutational burden","volume":"6","author":"Necchi","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.clgc.2025.102493_bib0019","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.urolonc.2020.05.004","article-title":"Radiation therapy in the management of the inguinal region in penile cancer: what\u2019s the evidence?","volume":"40","author":"Yuan","year":"2022","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.clgc.2025.102493_bib0020","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13139-024-00877-y","article-title":"Assessing 18F-FDG PET\/CT uptake and its correlation with molecular biomarkers in penile cancer","volume":"59","author":"Salazar","year":"2025","journal-title":"Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.clgc.2025.102493_bib0021","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102493_bib0022","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/ajcp\/aqaf022","article-title":"Biomarkers of response to antibody-drug conjugates (TROP2 and nectin-4) and the immune microenvironment (NKG7, PD-L1, and B7-H3) in penile squamous cell carcinoma","volume":"163","author":"Tekin","year":"2025","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.clgc.2025.102493_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.humpath.2023.10.003","article-title":"Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma","volume":"142","author":"Tekin","year":"2023","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.clgc.2025.102493_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100781","article-title":"Evaluation of nectin-4 and trop-2: implications for patient outcomes and therapy in penile cancer","volume":"38","author":"Mink","year":"2025","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.clgc.2025.102493_bib0025","doi-asserted-by":"crossref","first-page":"722","DOI":"10.5858\/arpa.2021-0592-RA","article-title":"Molecular pathogenesis of penile squamous cell carcinoma: current understanding and potential treatment implications","volume":"147","author":"Keller","year":"2023","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.clgc.2025.102493_bib0026","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jnci\/djz224","article-title":"PIK3CA Mutation in HPV-associated OPSCC patients receiving deintensified chemoradiation","volume":"112","author":"Beaty","year":"2020","journal-title":"J Nat Cancer Inst"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767325001934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T20:28:52Z","timestamp":1771705732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767325001934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1558767325001934"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102493","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Main Genomic Findings in Penile Cancer: An Update","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2025.102493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102493"}}